ZBH
59
2
KEY
33
-4
WFC
66
-5
CINF
37
6
SBUX
36
-3
BSX
61
2
RF
53
-3
ORLY
57
3
LRCX
43
-2
ETR
63
-3
CHD
42
-3
BEN
33
-5
KHC
22
-3
HIG
52
2
VFC
65
2
OI
28
3
GLW
48
-4
IVZ
48
-4
A
47
6
CI
38
-14
ZBH
59
2
KEY
33
-4
WFC
66
-5
CINF
37
6
SBUX
36
-3
BSX
61
2
RF
53
-3
ORLY
57
3
LRCX
43
-2
ETR
63
-3
CHD
42
-3
BEN
33
-5
KHC
22
-3
HIG
52
2
VFC
65
2
OI
28
3
GLW
48
-4
IVZ
48
-4
A
47
6
CI
38
-14
Financhill
Back

Outlook Therapeutics Vs. Brainstorm Cell Therapeutics Industry Stock Comparison

Sell
38

OTLK
Outlook Therapeutics

Last Price:
6.06
Seasonality Move:
-9.79%
Sell
6

BCLI
Brainstorm Cell Therapeutics

Last Price:
1.78
Seasonality Move:
11.28%
Sell
38
Outlook Therapeutics (OTLK) is a Sell

Is Outlook Therapeutics a Buy, Sell or Hold?

  • The current Outlook Therapeutics [OTLK] share price is $6.04. The Score for OTLK is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • OTLK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
6
Brainstorm Cell Therapeutics (BCLI) is a Sell

Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?

  • The current Brainstorm Cell Therapeutics [BCLI] share price is $1.80. The Score for BCLI is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

OTLK Stock Price Chart

What is Outlook Therapeutics's stock price today?

  • The Outlook Therapeutics share price today is $6.04
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OTLK is experiencing slight selling pressure.

BCLI Stock Price Chart

What is Brainstorm Cell Therapeutics's stock price today?

  • The Brainstorm Cell Therapeutics share price today is $1.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing selling pressure, which indicates risk of future bearish movement.

OTLK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 60.41 Buy
Chaikin Money Flow: -67113 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.08 - 5.7) Buy
Bollinger Bands (100): (5.76 - 7.98) Sell

BCLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 29.08 Sell
Chaikin Money Flow: -42665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.81 - 2.61) Sell
Bollinger Bands (100): (2.85 - 5.67) Sell

OTLK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.74 Buy
20-day SMA: 5.42 Buy
50-day SMA: 6.06 Sell
200-day SMA: 7.53 Sell
8-day EMA: 5.78 Buy
20-day EMA: 5.64 Buy
50-day EMA: 6 Buy
200-day EMA: 8.13 Sell

BCLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.92 Sell
20-day SMA: 2.05 Sell
50-day SMA: 3.16 Sell
200-day SMA: 5.53 Sell
8-day EMA: 1.92 Sell
20-day EMA: 2.19 Sell
50-day EMA: 3.01 Sell
200-day EMA: 6.29 Sell

Outlook Therapeutics Earnings Growth & OTLK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $1.39 per share.

Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.79 per share, and an increase next year of $0.67 per share.

Outlook Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Brainstorm Cell Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):